menu
    • menu

    Company profile for Excision BioTherapeutics

    NEW Drugs in Dev: 3
    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients. Excision BioTherapeutics is a private company focused on developing advanced gene editing therapeutics to address the medical need for the treatment of life-threatening disease caused by viral infections. Our mission is to advance gene editing therapeutics for our indications into safe and efficaci...
    Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients. Excision BioTherapeutics is a private company focused on developing advanced gene editing therapeutics to address the medical need for the treatment of life-threatening disease caused by viral infections. Our mission is to advance gene editing therapeutics for our indications into safe and efficacious medicines that will greatly improve the lives of infected individuals around the world.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Excision BioTherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    San Francisco , CA
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.excision.bio/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/excisionbiotherapeutics/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Clinical Outsourcing

    Clinical Outsourcing

    Not Confirmed

    envelop Contact Supplier

    Clinical Outsourcing

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Excision Bio Reports Positive Preclinical Data in HBV EBT-107
    Excision Bio Reports Positive Preclinical Data in HBV EBT-107

    15 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/15/3149947/0/en/Excision-BioTherapeutics-Announces-Positive-Preclinical-Data-Highlighting-the-Safety-Potency-and-Development-Progress-of-the-Hepatitis-B-EBT-107-Program-at-the-ICE-HBV-Hepatitis-B-.html

    GLOBENEWSWIRE
    15 Sep 2025
    Share Share
    Excision BioTherapeutics Highlights EBT-107 for Hepatitis B
    Excision BioTherapeutics Highlights EBT-107 for Hepatitis B

    15 May 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/05/15/3082145/0/en/Excision-BioTherapeutics-Announces-Publication-Highlighting-EBT-107-for-the-Treatment-of-Chronic-Hepatitis-B-in-bioRxiv.html

    GLOBENEWSWIRE
    15 May 2025
    Share Share
    Excision BioTherapeutics Presents Data at ASGCT 2025 Meeting
    Excision BioTherapeutics Presents Data at ASGCT 2025 Meeting

    13 May 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/05/13/3080119/0/en/Excision-BioTherapeutics-Presents-Data-from-HBV-and-HSV-Programs-at-the-ASGCT-2025-Annual-Meeting.html

    GLOBENEWSWIRE
    13 May 2025
    Share Share
    Excision BioTherapeutics Presents at Genome Editing Summit
    Excision BioTherapeutics Presents at Genome Editing Summit

    03 Dec 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/12/03/2990555/0/en/Excision-BioTherapeutics-Announces-Oral-Presentation-at-the-5th-Genome-Editing-Therapeutics-Summit.html

    GLOBENEWSWIRE
    03 Dec 2024
    Share Share
    EBT-107 Shows Antiviral Activity As Potential HBV Therapy
    EBT-107 Shows Antiviral Activity As Potential HBV Therapy

    16 Sep 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/09/16/2946572/0/en/Presentation-at-the-2024-International-HBV-Meeting-Highlights-Antiviral-Activity-of-EBT-107-as-a-Potential-Anti-HBV-Therapy.html

    GLOBENEWSWIRE
    16 Sep 2024
    Share Share
    Excision BioTherapeutics Announces Oral Presentation
    Excision BioTherapeutics Announces Oral Presentation

    09 Sep 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/09/09/2942748/0/en/Excision-BioTherapeutics-Announces-Oral-Presentation-at-the-2024-International-HBV-Meeting.html

    GLOBENEWSWIRE
    09 Sep 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search